The author list for this paper should appear as it does in this Addition and Correction. The affiliations for the authors are unchanged. Because Qiu Jin did a lot of work on CADD when revising the article (one of the reviewers suggested adding CADD research) and he gave many useful suggestions to revise the paper, we reconsider his contribution to the article and would like to give him the Co-corresponding Author. This article has not yet been cited by other publications.

中文翻译：

---

对发现 Chromane-6-Sulfonamide 衍生物作为一种有效的、选择性的和可口服的新型视黄酸受体相关孤儿受体 γt 反向激动剂的更正

这篇论文的作者列表应该像它在这个添加和更正中一样出现。作者的隶属关系不变。因为秋瑾在修改文章时对CADD做了很多工作（其中一位审稿人建议增加CADD研究），并且他对修改论文提出了很多有用的建议，我们重新考虑他对文章的贡献，并想给他Co ——通讯作者。这篇文章尚未被其他出版物引用。